GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Marksans Pharma Ltd (NSE:MARKSANS) » Definitions » Receivables Turnover

Marksans Pharma (NSE:MARKSANS) Receivables Turnover : 1.30 (As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Marksans Pharma Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Marksans Pharma's Revenue for the three months ended in Dec. 2023 was ₹5,861 Mil. Marksans Pharma's average Accounts Receivable for the three months ended in Dec. 2023 was ₹4,495 Mil. Hence, Marksans Pharma's Receivables Turnover for the three months ended in Dec. 2023 was 1.30.


Marksans Pharma Receivables Turnover Historical Data

The historical data trend for Marksans Pharma's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marksans Pharma Receivables Turnover Chart

Marksans Pharma Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.59 5.38 5.31 4.44 4.56

Marksans Pharma Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.18 1.16 1.20 1.18 1.30

Competitive Comparison of Marksans Pharma's Receivables Turnover

For the Drug Manufacturers - General subindustry, Marksans Pharma's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Marksans Pharma's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Marksans Pharma's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Marksans Pharma's Receivables Turnover falls into.



Marksans Pharma Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Marksans Pharma's Receivables Turnover for the fiscal year that ended in Mar. 2023 is calculated as

Receivables Turnover (A: Mar. 2023 )
=Revenue / Average Total Inventories
=Revenue (A: Mar. 2023 ) / ((Accounts Receivable (A: Mar. 2022 ) + Accounts Receivable (A: Mar. 2023 )) / count )
=18496.19 / ((3947.78 + 4168.46) / 2 )
=18496.19 / 4058.12
=4.56

Marksans Pharma's Receivables Turnover for the quarter that ended in Dec. 2023 is calculated as

Receivables Turnover (Q: Dec. 2023 )
=Revenue / Average Total Inventories
=Revenue (Q: Dec. 2023 ) / ((Accounts Receivable (Q: Sep. 2023 ) + Accounts Receivable (Q: Dec. 2023 )) / count )
=5861.27 / ((4495.18 + 0) / 1 )
=5861.27 / 4495.18
=1.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Marksans Pharma  (NSE:MARKSANS) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Marksans Pharma Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Marksans Pharma's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Marksans Pharma (NSE:MARKSANS) Business Description

Traded in Other Exchanges
Address
Veera Desai Extension Road, 11th Floor, Grandeur, Opposite Gundecha Symphony, Oshiwara, Andheri (West), Mumbai, MH, IND, 400053
Marksans Pharma Ltd is a pharmaceutical company. The company is engaged in the research, manufacturing, and marketing of pharmaceutical formulations. It manufactures analgesics, gastroenterology, anti-diabetic, cardiovascular, pain management, gynecology, gastrointestinal and oncologic drugs as well as antibiotics and antiallergic medications. It has a market presence with the majority of the revenue generated from the United States and North America, followed by Europe and the UK, Australia and New Zealand, India, and the Rest of the World.

Marksans Pharma (NSE:MARKSANS) Headlines

No Headlines